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Emergence of Antibiotic Resistance: MRSA 
 In 1928 the first antibiotic, Penicillin, was discovered by Alexander Fleming. When 
brought into practice this medication was also referred to as a miracle drug (Chambers and Deleo 
629). Antibiotics once cured infectious diseases that were before deadly and incurable. Though 
this was an incredible medical breakthrough, only a few years later antibiotic resistance emerged 
and became another medical problem that is difficult to combat (Chambers and Deleo 629). One 
of the major resistant infectious diseases, Methicillin resistant Staphylococcus aureus (MRSA), 
which is carried by many healthy people became a very prevalent issue for patients and 
healthcare professionals. “Methicillin resistant Staphylococcus aureus is one of the most 
common causes of infections, ranging from minor skin and soft tissue infections to severe, life-
threatening infections” (Cataldo, Taglietti, and Pestrosillo 16). MRSA is a very serious infection 
that can be used to show how antibiotic resistance occurs and how it effects all people. MRSA 
helps us understand the severity of antibiotic resistance and how it not only effects the general 
population, but every individual around the world. The most important aspect of reducing risk of 
antibiotic resistant bacterium is the understanding of this issue in not only healthcare 
professionals, but the general public as a whole. 
 Staphylococcus aureus is a bacteria that can be found in up to fifty percent of people with 
no symptoms. Although it can exist in a harmless, asymptomatic state, Staphylococcus aureus 
can also cause serious bacterial infections (Haile-Mariam 347). Staphylococcus aureus was once 
susceptible to all penicillins, but the bacteria became resistant after a few years of penicillin 
treatments in patients. When penicillin became less effective patients were introduced to newer, 
more potent antibiotics such as methicillin, which also eventually became ineffective to many 
Staphylococcus aureus bacteria. Staphylococcus aureus bacteria that are resistant are typically 
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called MRSA (Haile-Mariam 347). Information on antibiotic resistance has been minimal in the 
general public and with the prevalence of MRSA and other multidrug resistant bacterium, 
patients need to be aware of how antibiotic resistance can affect people throughout the entire 
world. 
 Despite of the fact that MRSA is a growing problem, many patients have trouble 
understanding the details of this infection. In a study of “Patients’ perspectives of antibiotic 
resistance,” by Lauren Brooks, patients were aware of MRSA and had resilient feelings on its 
occurrence in the hospital setting (HA-MRSA). Though the patients knew what MRSA was, 
most patients had never even heard the term antibiotic resistance (Brooks, et al 343). This 
presents a problem because patients are only seeing the disease and not where the disease is 
stemming from. Lauren Brooks study involved getting to the root of patients views on antibiotic 
resistance. Overall throughout her research, Brooks noticed that there were four major themes 
that occurred between the patients sampled. These themes include: whether either the body or 
bacteria are affected by antibiotic resistance, who is to blame, who is at risk, and potential 
solutions to the problem (Brooks, et al 343-345). Patients had a hard time distinguishing whether 
antibiotic resistance had emerged by the body or the bacteria gaining resistance to the antibiotics 
(Brooks, et al 343). As mentioned before, when first discovered, Penicillin was a cure for almost 
all Staphylococcus aureus bacterium, but not too long after its discovery cases of resistance were 
found. “More potent antibiotics were introduced and again, resistant bacteria emerged and 
flourished” (Haile-Mariam 347). It is important for patients to understand that the bacteria are 
the organisms that are becoming resistant, not their bodies. Bacteria adjust in a way that can 
reduce or eliminate the efficiency of antibiotics. When an antibiotic is taken, sometimes a few of 
the bacteria may survive because it offset or escaped the effect of the antibiotic (“Antibiotic 
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Resistance Questions and Answers”). These bacteria that may have escaped can then reproduce 
and supplant all the bacteria that were killed off. The surviving bacteria then become more 
resistant. The bacteria can change and “develop the ability to neutralize the antibiotic before it 
can do harm, others can rapidly pump the antibiotic out, and still others can change the antibiotic 
attack site so it cannot affect the function of the bacteria” (“Antibiotic Resistance Questions and 
Answers”). MRSA, found first in hospitalized patients (HA-MRSA), began to appear in the 
community (CA-MRSA) as the bacteria gained strength and became more resistant. The question 
that began to arise was what was causing the rise of resistant bacteria and Lauren Brooks found 
that patients had a lot of trouble deciding who to blame (Brooks, et al 344). 
 Moreover, when a multidrug resistant bacteria develops the natural response is to want to 
point fingers at who has caused this epidemic, but in reality there is no single cause for an 
infectious disease as complicated as MRSA (Haile-Mariam). Causes of antibiotic resistance can 
be pinned on just about every person who distributes or uses antibiotics. These people include: 
Physicians, patients, and pharmacists. When physicians write prescriptions, it is very common 
that it may have been written on a theoretical belief rather that proof of an infection (Thomas and 
Nandave 2064). Inappropriate use such as: theoretical belief of infection, incorrect dosage and 
length of prescription all lead to antibiotic resistance and can be helped with scientific proof of 
infection and physicians spending more time interpreting the type of bacteria causing this illness 
(Thomas and Nandave 2065). Patients’ role in antibiotic resistance is much more difficult to 
control. Patients fail to follow prescription directions, demand prescription from physicians when 
an infection is not present, and use leftover antibiotics for a different illness. Antibiotics are very 
specific and work only to kill bacterial infections (Thomas and Nandave 2065). Viral infections 
will not be cured by antibiotics and only certain antibiotics may be used to exterminate each 
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different bacterium. Pharmacists’ play a part in antibiotic resistance by: improper reading of 
prescriptions, not giving patients sufficient direction for prescriptions, and improper labeling of 
drugs (Thomas and Nandave 2065). The entire community plays a role in antibiotic resistance 
and blame cannot be placed on a single group of people. Antibiotic resistance requires change on 
the individual as well as the community as a whole (Brooks, et al 345). 
 In addition, patients had a hard time deciphering whether MRSA and antibiotic resistance 
could affect them personally or whether it was just a problem that affected others in the 
community (Brooks, et al 345).  “Antibiotic resistance leads to failed treatments, prolonged 
hospitalizations, increased costs and death” (Gyssens 12). Staphylococcus aureus is a very 
adaptable bacteria and effects healthy and sick people (Chambers and Deleo 629). The fact that 
MRSA can effect healthy and sick people is proof that every individual should understand the 
risks for them at a personal level and also of their community. MRSA affects overall healthy 
indivuduals by a strain called community associated MRSA (CA-MRSA) and ill people by a 
strain called healthcare associated MRSA (HA-MRSA). 
 MRSA was once isolated to cases only in the hospital, but it since it epidemiology has 
been altered and can be observed more often in the community. HA-MRSA refers to a strain that 
was attained after recent contact with a healthcare facility (Cataldo, Taglietti, and Pestrosillo 16). 
Risks that may lead to HA-MRSA include: being in the hospital in the last twelve months, recent 
dialysis procedure, living in a long-term care facility, and “presence of an indwelling catheter” 
(Cataldo, Taglietti, and Pestrosillo 17). CA-MRSA is characterized by a patient that has no prior 
infection of an antibiotic resistant infection and no recent exposure to a healthcare facility. CA-
MRSA is typically contracted by skin-to-skin contact between an individual with MRSA and 
another individual (Cataldo, Taglietti, and Pestrosillo 17). There are also risks involved in 
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contracting CA-MRSA that are the major reasons for infection. These risks include: 
“Compromised skin integrity, skin-to-skin contact with infected or colonized persons, 
suboptimal personal hygiene, sharing of contaminated objects and surfaces, and living in 
crowded conditions” (Cataldo, Taglietti, and Pestrosillo 17). CA-MRSA can typically occurs in 
three different types of infections. The most common routes of infection are skin and soft tissue, 
musculoskeletal, and pneumonia. The most complicated infection to treat is pneumonia and the 
mortality rate of this infection is significantly higher than the other routes. Pneumonia caused by 
MRSA has been reported much more often in recent year in the community and demonstrates 
just how important limiting risk of MRSA and antibiotic resistance is (Cataldo, Taglietti, and 
Pestrosillo 18).  
 Currently, there are some methods that are used to cure MRSA, though there are cases in 
which these methods are not effective. These methods include medications such as Clindamycin, 
Cotrimoxazole, Doxycycline, and most commonly Vancomycin. Vancomycin, usually in an 
intravenous form, has the capability to fight against the most severe MRSA infections (Cataldo, 
Taglietti, and Pestrosillo 19). Though it is the most commonly used, but resistance still remains a 
huge factor in the effectiveness of this therapy (Chambers and Deleo 638). Considering that 
these medications that are commonly used to treat MRSA can still become resistant, new policies 
and ideas have been brought up in order to reduce the prevalence of antibiotic resistance rather 
than hope the medications work once the disease is already contracted. There have been 
“Antibiotic Stewardship” programs in which give patients guidelines on antibiotic use (Gyssens 
12).  
 Before modern day antibiotics were created, illness such as Staphylococcus aureus were 
fatal in almost every case. The problem that antibiotic resistance creates is that this problem is 
6 
 
occurring again. With resistance on the rise and the likelihood that our society will one day be 
resistant to almost all antibiotic is a reality (Haile-Mariam 346). Patients often believe that 
multidrug resistant bacteria will not affect them, but this is simply not the case. “They [patients] 
did not consider themselves to be at risk, because they either portrayed themselves as 
‘responsible’ users of antibiotics or perceived that they had not consumed sufficient quantities of 
antibiotics” (Brooks, et al 345). Patients also do not understand that irresponsible patients that 
are misusing antibiotic can affect the entire community. Abuse of antibiotics has the capability of 
effecting people all over the world (Brooks, et al 345). “There is a clear association between 
antibiotic use and resistance both on the individual and population levels” (Gyssens 12). While 
resistance becomes more prevalent, the treatment options become scarce. This scarcity can 
eventually lead patients to high risk situations including death (Gyssens 12). In order to help 
prevent this problem, the key is to reach patients so they understand the severity of this problem. 
 There are several ways of reaching patients that are currently being used by healthcare 
professionals and evidence that there has been many benefits of these campaigns. Some common 
methods used to reach patients include: antibiotic education in schools, education sessions for 
prescribers, health education websites, television programs, and educational materials mailed to 
homes (Hemo, et al 19-23). The benefits of these programs are excellent and help patients grow 
in their understanding in this growing epidemic of antibiotic resistance. 
 To illustrate how patients benefit from the programs, a study on antibiotic education in 
schools and education sessions by Diane Harris produced brilliant results. In schools students 
would take a quiz on their knowledge on antibiotics and then take home key facts about suitable 
use of antibiotics (Harris 2425). The children were taught about the use of antibiotics were 
shown to enjoy it and through the leaflet they brought home to parents Harris two different 
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Figure 1.Improvement Statistics. (Madle, et al 21). This image shows how patients 
answered questions on their questionnaire before and after they viewed a health education 
website on antibiotic resistance.   
groups of people by basic education in schools by trained school health assistants (Harris 2427). 
During education sessions a local microbiologist, microbial pharmacist, and an infection control 
nurse would be present to help inform antibiotic prescribers. These sessions included information 
on antibiotic prescribing, followed by a discussion (Harris 2427). The end result of these sessions 
was prescriber’s knowledge on helping patients understand risks of antibiotics through 
pamphlets at their primary care physician. Not only did the prescribers think that these sessions 
were helpful for themselves, but they felt they had more confidence in reaching out to the public 
with information on antibiotic resistance (Harris 2427). 
 Health education websites have been known to be very helpful to patients and make it 
easier to cover a large audience. Gemma Madle launched a website that informed patients of 
frequently asked questions 
about antibiotic resistance and 
evidence-based resources that 
go into greater depth about 
antibiotics (Madle, et al 20). In 
order to find out how effective 
informative websites on 
antibiotic resistance were, 
Madle asked patients to fill out a questionnaire on antibiotic before and after they viewed the 
website. All of the patients thought that their knowledge had grown about antibiotics and fourty-
seven percent of patients showed an improvement in knowledge of antibiotics from the first 
questionnaire (Madle, et al 21). Figure 1 displays data on the questions that patients may have 
improved or worsened on their questionnaire. Though this evidence demonstrates that not all 
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patients had an improvement of their knowledge, it is excellent that this showed some 
improvement. Also this information can help healthcare professional see where they can make 
improvement on getting the right information to their patients. A physician who saw the 
educational website even said “I would recommend this to my patients instead of rushing in to 
see me as their general practitioner” (Madle, et al 25). This evidence indicates that with just 
small steps to reach patients, such as website, patients’ knowledge can improve. Though this 
source is about ten years old, using the internet as a mode of information to reach patients is 
more helpful now because knowledge of computers, as well as access to computers is more 
prevalent at this point in time. 
 Beatriz Hemo conducted a study on how a “nationwide media campaign can affect 
antibiotic use” (Hemo, et al 529). This campaign included: television presentations, pamphlets 
and educational resources mailed to the home. Hemo found that the most effective way to help 
patients understand implications involved in antibiotic use was by a combination of strategies 
(Hemo, et al 529). As seen in Madle’s study, only fourty seven percent of people improved on 
their questionnaire after they viewed the educational website (Madle, et al 21). Through both of 
these studies, it becomes apparent that in order to have the full effect of knowledge about 
antibiotic resistance, a few different modes of information will work best. Collecting information 
from a multitude of different sources will help patients get a tighter grasp on how antibiotic 
resistance affect them as well as the community. The results of the nationwide campaign by 
Hemo, demonstrated that there were not only short-term results, but also a change in attitude of 
patients about the prescription of antibiotics. Overall through this study it is apparent that 
nationwide campaigns about misuse of antibiotics can reduce overuse of antibiotics (Hemo, et al 
534). 
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 Therefore, since only a few years after antibiotics were invented, antibiotic resistance has 
been a problem. There is a lot of information that patients lack, as well as lack to understand. 
MRSA has shown us the harsh reality of antibiotic resistance and how adaptable it can be. 
Though there are medications that can rid the body of these bacteria now, the bacteria become 
more resistant every time antibiotics are used (Haile-Mariam 347). Patients are responsible in 
knowing basic information about their bodies and how antibiotic resistance can affect them and 
everyone around them. Though the many modes of information that have been used over the 
years, it has been proven that antibiotic education in schools, education sessions for prescribers, 
health education websites, television programs, and educational materials mailed to homes can 
help patients be more aware of the epidemic of antibiotic resistance.  
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